Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

• Der Einfluß von Dienogest auf die Ovulation junger Frauen und auf weitere ausgewählte endokrinologische Parameter via openalex
• doi:10.1016/s0015-0282(16)60967-6 via openalex
• doi:10.1136/bmj.1.6056.293 via openalex
• doi:10.1016/0002-9378(89)90655-8 via openalex
• doi:10.1007/s40278-026-93643-1 via openalex
• doi:10.1136/bmj.2.5703.231 via openalex
• W2186866099 via openalex
• W2300692921 via openalex
• W6608074919 via openalex
• W6796651853 via openalex
• doi:10.1016/s0010-7824(96)00183-7 via openalex
• doi:10.1007/bf01849485 via openalex
• doi:10.1016/0010-7824(79)90045-3 via openalex
• doi:10.1136/bmj.1.4647.231 via openalex
• doi:10.1016/s0002-9378(16)32484-x via openalex
• doi:10.1007/bf01986524 via openalex
• doi:10.1136/bmj.2.5704.293 via openalex
• doi:10.1136/bmj.293.6547.601 via openalex
• doi:10.1016/0002-9378(90)90596-y via openalex
• doi:10.1016/0010-7824(96)00137-0 via openalex
• doi:10.1016/s0002-9378(87)80129-1 via openalex
• doi:10.1007/978-3-642-73790-9_8 via openalex
• doi:10.1016/0010-7824(95)00228-6 via openalex

Cited by (12)

• An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest 2012
• Ethinylestradiol/Dienogest in Oral Contraception 2010
• Review of clinical experience with estradiol in combined oral contraceptives 2009
• Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest 2009
• Original research article Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies ☆,☆☆ 2008
• Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies 2008
• Progestogens with Antiandrogenic Properties 2003
• THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDY 2000
• The efficacy and tolerability of Valette®: a postmarketing surveillance study 1999
• Clinical profile of Valette® 1999
• Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives 1998
• Dienogest 1998

Source provenance

openalex

last seen: 2026-05-11T06:24:00.257642+00:00

unpaywall

last seen: 2026-06-02T02:00:03.124865+00:00